The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review

Clicks: 186
ID: 272776
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia (HPRL) as a common adverse effect of antipsychotic medication, which remains the cornerstone of pharmacological treatment for patients with schizophrenia. Although treatment with second-generation antipsychoti …
Reference Key
j2014cnsthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Peuskens J;Pani L;Detraux J;De Hert M;;
Journal cns drugs
Year 2014
DOI
DOI not found
URL
https://www.pubmed.gov/24677189/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine Hyperprolactinemia / epidemiology prolactin / metabolism prolactin / blood* antipsychotic agents / adverse effects pmid:24677189 pmc4022988 doi:10.1007/s40263-014-0157-3 j peuskens l pani m de hert antipsychotic agents / pharmacology* hyperprolactinemia / chemically induced hyperprolactinemia / diagnosis hyperprolactinemia / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.